🔬Hitachi to begin demonstration test on cancer test using urine specimen
Accelerated research for practical application of cancer tests with urinary metabolites by conducting a verification test for about 6 months
Hitachi, Ltd. will begin demonstration tests for the first time in the field of in-vitro diagnostics for the practical application of cancer tests using urine samples from April 2018. In this demonstration test, trace and time management of temperature at the time of sample transport from collection of urine sample with clinical information (presence / absence of cancer), biomarker * 2 by liquid chromatography / mass spectrometer (LC / MS) * 1 We will conduct a series of analysis flow for a half year (repeat), such as quantitative analysis of cancer model, construction of cancer test model, risk discrimination of cancer based on it, examination of validity of clinical information and judgment result.
In this demonstration test, LC / MS · quantitative analysis will be carried out with the cooperation of Cimic Pharma Science Co., Ltd.
The evaluation of analysis data will be carried out with the cooperation of the Nagoya University Medical School Hospital.
Hitachi, Ltd -Translated by TkioX